Table 3 Hazard ratios (Cox regression analysis) for the combined endpoint (acute myocardial infarction, stroke, death of all causes) for the entire follow-up period
Variable | Univariate | Multivariate |
|---|---|---|
Hazard ratio (95% Confidence interval) | ||
C-reactive protein | ||
Quartile 4 (Quartile 1 is reference) | 3.0 (1.9–5.0) | 2.0 (1.1–3.7) |
Age (continues variable) | 1.06 (1.0–1.1) | 1.05 (1.0–1.1) |
Sex | ||
Male | 1.0 | 1.0 |
Female | 1.3 (0.9–1.8) | 0.9 (0.6–1.3) |
Current smoker | ||
No | 1.0 | 1.0 |
Yes | 0.9 (0.6–1.4) | 1.6 (1.0–2.6) |
Diabetes | ||
No | 1.0 | 1.0 |
Yes | 1.6 (1.1–2.4) | 1.5 (1.0–2.4) |
Clinical heart failure During hospitalization | ||
No | 1.0 | 1.0 |
Yes | 3.1 (2.2–4.4) | 1.8 (1.2–2.6) |
Atrial fibrillation | ||
No | 1.0 | 1.0 |
Yes | 2.3(1.6–3.3) | 1.6 (1.1–2.4) |
Glomerular filtration rate | ||
>60 ml/min | 1.0 | 1.0 |
<60 ml/min | 2.5 (1.8–3.5) | 1.2 (0.8–1.7) |
Troponin T, quartile 4 (Quartile 1 is reference) | 1.7 (1.1–2.7) | 1.0 (0.6–1.8) |
Platelet Aggregation | ||
Quartile 4 (Quartile 1 is reference) | 2.0 (1.2–3.3) | 1.1 (0.6–2.0) |
High residual platelet reactivity | ||
No | 1.0 | 1.0 |
Yes | 0.8 (0.5–1.1) | 0.7 (0.5–1.0) |
CABG | ||
No | 1.0 | 1.0 |
Yes | 0.5 (0.3–0.9) | 0.5 (0.3–1.0) |
PCI | ||
No | 1.0 | 1.0 |
Yes | 0.4 (0.3–0.7) | 1.0 (0.6–1.8) |